Search Results 771-780 of 17195 for treatment resistant depression
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies · Share · Facebook · Twitter.
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study ...
About this study. The purpose of this 3-part study, comprising a phase 1b dose escalation, dose expansion, and a phase 2, is to assess the safety, ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
... treatment with mTOR inhibitors sirolimus or everolimus as part of their clinical care. ... Post Approval Study for Treatment of Drug-resistant Adult Primary FSGS ...
In addition to having chronic pain, some people have depression or anxiety. Psychologists provide group-based cognitive behavioral treatments and if ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
The purpose of this study is to evaluate the safety and effectiveness CTX110 in subjects with relapsed or refractory B cell malignancies. Participation ...
Radiotherapy treatment planning requires precise calculations of ... resistant to therapy. These activities are a first step toward identifying ...
... depression, anxiety disorders, schizophrenia, eating disorders and addictive ... therapy for older men. Here's the Mayo Clinic Radio podcast. The post Mental ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.